PharmiWeb.com - Global Pharma News & Resources
27-Nov-2018

Autoimmune & Inflammation: Disease & Epidemiology Overviews - 2018 Report - ResearchAndMarkets.com

The "Autoimmune & Inflammation: Disease & Epidemiology Overviews" report from Decision Resources Group has been added to ResearchAndMarkets.com's offering.

Autoimmune & Inflammation: Disease & Epidemiology Overview, provides disease market overviews and global epidemiology overviews for 18 indications in the Autoimmune & Inflammation therapy area:

  • Atopic Dermatitis/Atopic Eczema
  • Psoriasis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Ulcerative Colitis
  • Acute Respiratory Distress Syndrome
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Cystic Fibrosis
  • Idiopathic Pulmonary Fibrosis
  • Axial Spondyloarthritis
  • Juvenile Idiopathic Arthritis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Scleroderma (Systemic Sclerosis)
  • Sjogren's Syndrome
  • Systemic Lupus Erythematosus
  • Graft Versus Host Disease

This report provides a disease market overview for each indication and global epidemiology overviews for each indication. The disease market overviews include information such as market size forecasts, prevailing treatment trend analysis and predictions, key areas of unmet need, current and emerging therapies, physician (KOL) insights, clinical pipeline analysis, and more, for each indication.

The global epidemiology overviews provide insights including global diagnosed prevalence, diagnosed prevalence by region, 10-year diagnosed prevalence growth forecast, relative sizes of the factors contributing to the trend in prevalent cases, and more, for each indication.

Companies Featured

  • Boehringer Ingelheim
  • FibroGen
  • Mallinckrodt
  • Promedior
  • Prometic Life Sciences
  • Roche

Key Topics Covered

1. Disease Landscape and Insight Overview
2. Epidemiology Overview
3. About the Authors & Epidemiologists

For more information about this report visit https://www.researchandmarkets.com/research/wzvg5k/autoimmune_and?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181127005555/en/

Editor Details

Last Updated: 27-Nov-2018